Equity Actions
PBLA
Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares plummeted by 65.5% to $1.47 after announcing a public offering priced at approximately $9 million. Other stocks experienced significant movements in Monday's mid-day session, with various companies showing notable gains and losses. Gainers included Palisade Bio, Inc. (NASDAQ:PALI), OneMedNet Corporation (NASDAQ:ONMD), and Revelation Biosciences, Inc. (NASDAQ:REVB), among others. Losers featured SMX (Security Matters) Public Limited Company (NYSE:SMX), Inspire Veterinary Partners, Inc. (NASDAQ:IVP), and Bullfrog AI Holdings, Inc. (NASDAQ:BFRG), among others.
Portfolio Pulse from
Avi Kapoor
January 29, 2024 | 7:09 pm
RXST
Over the past three months, 8 analysts have provided ratings for RxSight (NASDAQ:RXST), with sentiments ranging from bullish to bearish. The average 12-month price target for RXST is $42.38, with a high of $54.00 and a low of $30.00, marking a 3.37% increase from the previous target of $41.00. Analysts from firms like Oppenheimer, Needham, Wells Fargo, Stifel, and Morgan Stanley have updated their ratings and price targets, reflecting their views on the company's market performance. RxSight, a medical technology company, has shown a revenue growth of 75.97% as of September 30, 2023, but struggles with profitability and efficiency, as indicated by its net margin of -55.93%, ROE of -7.79%, and ROA of -6.58%. The company has a low debt-to-equity ratio of 0.02.
Portfolio Pulse from
Benzinga Insights
January 29, 2024 | 7:00 pm
COIN
Coinbase Global, Inc. (NASDAQ:COIN) stock is trading higher, influenced by the recent increase in Bitcoin's price and a positive analyst upgrade. Bitcoin's price has risen over 8% in the past five days, positively impacting crypto-related stocks like Coinbase. Oppenheimer analyst Owen Lau upgraded Coinbase from Perform to Outperform with a price target of $160, citing potential favorable outcomes in ongoing litigation with the SEC and benefits from the approval of spot Bitcoin ETFs.
Portfolio Pulse from
Erica Kollmann
January 29, 2024 | 6:07 pm
MUR
Analysts have mixed views on Murphy Oil (NYSE:MUR), with recent ratings ranging from bullish to bearish. The average 12-month price target is $50.17, a slight decrease from the previous $51.20. Analysts from UBS, Piper Sandler, Keybanc, and Truist Securities have adjusted their ratings and price targets, reflecting changes in market dynamics and company performance. Murphy Oil, an independent oil and gas company, reported a revenue decline of -11.69% as of December 31, 2023, and faces challenges in profitability and asset utilization, with a net margin of 13.81%, ROE of 2.17%, and ROA of 1.18%. The company's debt-to-equity ratio is below the industry average at 0.39.
Portfolio Pulse from
Benzinga Insights
January 29, 2024 | 6:00 pm
AXP
Analysts have recently updated their ratings and price targets for American Express (NYSE:AXP), with 11 analysts offering a range of opinions. The average 12-month price target is now $198.27, up from the previous $189.00. Analysts from firms like RBC Capital, UBS, and BMO Capital have raised their price targets, while others have announced new ratings. American Express has shown strong financial performance with a 13.57% revenue growth rate, a net margin of 15.76%, an ROE of 8.95%, an ROA of 0.98%, and a debt-to-equity ratio of 1.76.
Portfolio Pulse from
Benzinga Insights
January 29, 2024 | 6:00 pm
AHCO
AdaptHealth (NASDAQ:AHCO) has received mixed analyst ratings over the past three months, with 2 bullish, 1 somewhat bullish, and 1 somewhat bearish. The average 12-month price target is now $9.88, down from $14.00, with a high estimate of $13.00 and a low of $6.50. Analysts from UBS, RBC Capital, B of A Securities, and Truist Securities have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. AdaptHealth's financials show a market cap below industry benchmarks, a revenue growth of 4.67%, a net margin of -77.8%, an ROE of -23.21%, an ROA of -9.15%, and a debt-to-equity ratio of 1.33.
Portfolio Pulse from
Benzinga Insights
January 29, 2024 | 6:00 pm
BP
CVX
HES
PXD
XOM
Activist investor Bluebell Capital Partners has urged BP plc (NYSE:BP) to reduce its green energy commitments, claiming these have depressed BP's share price. Bluebell's call contrasts with previous activist campaigns, such as Engine No. 1's successful push for ExxonMobil Corp. (NYSE:XOM) to adopt more environmentally friendly policies. Exxon and Chevron (NYSE:CVX) have recently made large acquisitions in the shale oil and gas sector, with Exxon purchasing Pioneer Natural Resources Co (NYSE:PXD) and Chevron acquiring Hess Corp (NYSE:HES). Bluebell suggests BP cut investments in bioenergy, hydrogen, and renewables by $28 billion by 2030. The debate over oil majors' green energy targets and potential M&A activity is expected to intensify in the coming months.
Portfolio Pulse from
Neil Dennis
January 29, 2024 | 5:20 pm
BE
BFRG
CDLX
PALI
PBLA
SOFI
U.S. stocks traded mixed with the Dow slightly down and the Nasdaq up. Consumer discretionary shares rose, while energy shares fell. Palisade Bio surged after withdrawing a registration statement and announcing preclinical data. SoFi Technologies jumped on strong quarterly revenue. Cardlytics gained after a settlement agreement and updated Q4 results. Panbela Therapeutics plunged following a public offering announcement. Bullfrog AI fell after a shelf offering, and Bloom Energy dropped after a downgrade. Oil prices decreased, while gold and silver rose.
Portfolio Pulse from
Avi Kapoor
January 29, 2024 | 5:16 pm
REVG
REV Group Inc (NYSE:REVG) shares surged after announcing a special dividend and strategic actions, including the sale of its Collins Bus Corporation to Forest River Bus, LLC for $303.0 million and the planned exit from transit bus manufacturing by shutting down its ENC business. The company will reorganize into two segments, Specialty Vehicles and Recreational Vehicles, and expects to generate $250 million in net cash proceeds, returning $180 million to shareholders as a special dividend. The dividend is payable on February 16, 2024, to shareholders of record on February 9, 2024. Remaining proceeds will be used to reduce debt. REV Group will update its fiscal 2024 guidance in its upcoming earnings release.
Portfolio Pulse from
Lekha Gupta
January 29, 2024 | 5:04 pm
BETZ
DKNG
FLUT
Flutter Entertainment plc (NYSE:FLUT), parent of FanDuel, has listed on the NYSE, transitioning from its OTC listing under PDYPY. This move could impact DraftKings Inc (NASDAQ:DKNG) as investors may rotate from DraftKings to Flutter due to its new accessibility and status as a pure-play sports betting and gaming company. Flutter's Q4 revenue was up 15% YoY, with FanDuel holding a 43% gross revenue market share in the U.S. sportsbook market. Flutter's NYSE listing is seen as a strategic move to access deeper capital markets and align with its significant U.S. presence. Flutter is also the largest holding in the Roundhill Sports Betting & iGaming ETF (NYSE:BETZ) at 11.0%. Flutter shares are up 0.88% to $206.80.
Portfolio Pulse from
Chris Katje
January 29, 2024 | 5:01 pm
Previous
Next